Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00383032 · ClinicalTrials.gov registry record · NA
Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT00383032 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 72 participants.
The verdict
NCT00383032, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
Data from other countries have suggested that oral mifepristone used as a cervical ripening agent may decrease induction to delivery time in midtrimester inductions. To our knowledge, there are no trials comparing mifepristone to laminaria in a standard clinical setting with standardized misoprostol induction protocol to examine the issue of induction to delivery time. We hypothesize that mifepristone will work at least as well as laminaria for midtrimester cervical ripening prior to induction of labor with misoprostol.
Interventions
- DRUG mifepristone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00383032
The ClinicalTrials.gov registry entry for NCT00383032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mifepristone is the first listed.
NCT00383032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00383032 about?
NCT00383032 is a clinical study titled "Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction". Data from other countries have suggested that oral mifepristone used as a cervical ripening agent may decrease induction to delivery time in midtrimester inductions. To our knowledge, there are no trials comparing mifepristone to laminaria in a standard clinical setting with standardized misoprostol...
What is the current status of trial NCT00383032?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2004-01. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00383032?
The interventions under investigation include: mifepristone (DRUG).
Who is sponsoring clinical trial NCT00383032?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.